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Increasing evidence suggests that the cytoplasmic tail of
membrane type 1matrixmetalloproteinase (MT1-MMP) is sub-
ject to phosphorylation and that this modification may influ-
ence its enzymatic activity at the cell surface. In this study, phos-
phorylated MT1-MMP is detected using a phospho-specific
antibody recognizing a protein kinase C consensus sequence
(phospho-TXR), and a MT1-MMP tail peptide is phosphoryla-
ted by exogenous protein kinaseC.To characterize the potential
role of cytoplasmic residue Thr567 in these processes, mutants
that mimic a state of either constitutive (T567E) or defective
phosphorylation (T567A) were expressed and analyzed for their
functional effects on MT1-MMP activity and cellular behavior.
Phospho-mimetic mutants of Thr567 exhibit enhanced matrix
invasion aswell asmore extensive growthwithin a three-dimen-
sional type I collagenmatrix. Together, these findings suggest that
MT1-MMPsurface action is regulatedbyphosphorylation at cyto-
plasmic tail residue Thr567 and that this modification plays a criti-
cal role in processes that are linked to tumor progression.
Largely composed of a mixture of collagens, laminins, and
vitronectin, the extracellular matrix (ECM)2 serves as both a
physical scaffold and a barrier against cell invasion. It has
become increasingly evident that the structural condition of the
ECMplays a unique role in regulating cell behavior. Proteolysis
of integral components of the basementmembrane disturbs the
barrier provided by the ECM. Without physical restriction,
cells invade the surrounding environment in an unregulated
manner. The ability of matrix metalloproteinases (MMPs) to
collectively degrade nearly all ECM constituents allows this
class of enzymes to function in a diverse range of physiological
processes (1, 2). Of the anchored MMPs, membrane type 1
matrix metalloproteinase (MT1-MMP) was the first to be dis-
covered and has been most thoroughly characterized. Unlike
solubleMMPs,MT1-MMPhas a stretch of hydrophobic amino
acids that traverse the cell membrane, followed by a short cyto-
plasmic tail composed of 20 amino acids (3). The advantage of
cell surface localization is 2-fold. Surface restriction allows
MT1-MMP tomodify the immediate pericellular environment,
overcoming physical constraints imposed by the ECM (2).
Localization at the cell surface also places tetheredMMPs in an
optimal position to function at invadapodia, highly specialized
areas of the cell membrane that form during focalized cell inva-
sion (4). Although information regarding the role of the cyto-
plasmic tail is relatively limited (5, 6), this domainmay function
as a bridge to the intracellular machinery.
MT1-MMP has an essential role in matrix remodeling dur-
ing physiological processes (7, 8). Conversely, its enzymatic
activity is key to acquiring ametastatic phenotype in a variety of
tumor cells, including lung, colon, breast, and cervical carcino-
mas (2, 9–11). The ability to alter the physical structure of the
pericellular environment, while triggering the activation and
modification of several cell surface proteins, identifies a central
role for MT1-MMP in influencing cellular behavior (12). In
return, stringent cellular regulation of MT1-MMP enzymatic
activity is necessary to prevent aberrant proteolysis.
Increasing evidence suggests that the cytoplasmic tail of
MT1-MMP may regulate its activity at the cell surface. It has
been demonstrated that MT1-MMP is internalized from the
cell surface and that this process requires the presence of the
cytoplasmic domain (5, 6). Tail truncation restrictsMT1-MMP
to the cell surface, suggesting that this domain contains
sequence(s) that either mediate internalization or are required
for physical interaction with another protein that facilitates its
internalization (5, 6). The mechanism regulating this process
has yet to be determined. Interestingly, both invasion and
migration are down-regulated in cells where MT1-MMP is
restricted to the cell surface (5, 6). These data suggest a corre-
lation between internalization and matrix turnover, where
MT1-MMP activity is either abrogated or enhanced under
appropriate stimuli.
Reversible phosphorylation is widely recognized as a key
post-translational modification that regulates protein function.
The cytoplasmic domain of MT1-MMP has three potential
phosphorylation sites: Thr567, Tyr573, and Ser577. Recent work
by Nyalendo et al. (13) indicates that MT1-MMP is phospho-
rylated at tyrosine residue Tyr573, and that this modification
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influences cell migration. Several surface proteins are regulated
by phosphorylation at multiple residues. In the MT1-MMP
cytoplasmic tail, Thr567 has homology with the consensus
sequence for both protein kinase C (TXR) and ERK1/2 (XTP)
(14), suggesting the possibility that active MT1-MMP might
also be regulated through phosphorylation of this cytoplasmic
tail residue. In the present study, we report that MT1-MMP
bears a threonine phosphorylation site in its cytoplasmic tail
and that this modification plays an important role in regulating
several aspects of carcinoma cell behavior, including invasion
and three-dimensional growth.
EXPERIMENTAL PROCEDURES
Materials—Anti-FLAGmonoclonalM2 antibody and perox-
idase-conjugated secondary antibodies were purchased from
Sigma. Anti-MT1-MMP (hinge or catalytic domain) antibodies
were purchased from Chemicon or Abcam. Antibodies
directed against phosphothreonine were obtained from Cell
Signaling Technologies (Danvers, MA) or Abcam. Calyculin A
(serine-threonine phosphatase inhibitor) was purchased from
Cell Signaling Technologies. Super Signal-enhanced chemilu-
minescence reagents were purchased from Pierce. Rat tail col-
lagen type I and Matrigel Basement Membrane Matrix were
purchased from BD Biosciences. Gold chloride was purchased
from Fisher. TIMP-2 (tissue inhibitor of metalloproteinase-2)
was graciously provided by Dr. Rafael Fridman (Wayne State
University, Detroit, MI).
Cell Culture—The breast cancer cell line MDA MB 231 was
kindly provided byDr. V. Craig Jordan (Fox Chase Cancer Cen-
ter, Philadelphia, PA) and was maintained in minimal essential
medium containing 10% fetal bovine serum. Cell culture media
and reagents were purchased fromMediatech (Herndon, VA).
DNA Constructs and Generation of Stable Cell Lines—The
human MT1-MMP cDNA with C-terminal FLAG tag (DYKD-
DDDK)was kindly provided byDr. Duanqing Pei (University of
Minnesota, Minneapolis, MN). The open reading frame
sequences of MT1-MMP cDNA were TA-subcloned into
eukaryotic expression vector pCR3.1-Uni (Invitrogen) to
obtain the wild type construct. To facilitate different studies,
the wild type construct was further FLAG-tagged in the stalk
region, as described (15). Subsequently, the T567A and T567E
point mutations were generated on the wild type cDNA and on
the tagged constructs using QuikChange (Stratagene). Trans-
fection of cells was done using FuGENE 6 (Roche Applied Sci-
ence) according to the manufacturer’s instructions, and stable
cell lines were generated using G418 selection. These cells were
selected because they express endogenous MT1-MMP, insur-
ing proper activation of the proMT1-MMP zymogen, as well as
key components of the pro-MMP-2 activation system (i.e. pro-
MMP-2 and TIMP-2), thereby facilitating the assay of potential
functional changes brought about by phosphorylation. Stable
cell lines were generated using G418 selection, and cells were
sorted by fluorescence-activated cell sorting using an antibody
against the FLAG epitope tag (M2). To ensure equivalent
expression levels, cells were sorted using anti-FLAG M2 every
3–5 passages. All experiments were performed with freshly
sorted cell populations.
Kinase Assays—Analysis of PKC-dependent phosphoryla-
tion of a purified synthetic MT1-MMP tail peptide was per-
formed as described previously (16). Briefly, substrate (MT1-
MMP tail peptide or histoneH1 (45g/ml))was incubatedwith
recombinant PKC (3.5 nM) in 45 M -glycerol phosphate
buffer, pH 7.0, containing 0.9mM dithiothreitol, 9.0mMMgCl2,
0.45 mM CaCl2, and 4.5 M ATP in the presence or absence of
the activators phosphatidylserine (45g/ml) and diacylglycerol
(1.6 g/ml) (as indicated). Reactions were initiated by the addi-
tion of 5 Ci of [-32P]ATP and were terminated by the addi-
tion of 50 l of 3 Laemmli SDS stop solution and thermal
denaturation at 100 °C for 5 min (16) prior to separation on a
12% SDS-polyacrylamide gel and autoradiography.
Gelatin Zymography—Gelatinase activities in conditioned
media were determined using SDS-polyacrylamide gel electro-
phoresis zymography. Conditioned media (20 l) from an
equivalent number of cells were electrophoresed without
reduction on SDS-polyacrylamide gels prepared with 9% acryl-
amide containing 0.1% gelatin. SDSwas removed through a 1-h
incubation in 2.5% Triton X-100, and gels were incubated in 20
mM glycine, 10mMCaCl2, 1 MZnCl2 (pH 8.3) at 37 °C for 24 h
prior to staining for gelatinwithCoomassie Blue. Enzyme activ-
ity was visualized as zones of gelatin clearance within the gels.
MT1-MMP Immunoprecipitation and Immunoblotting—
ForWestern blotting of whole cell lysates, cells were lysed using
50 mM Tris, pH 7.5, 150 mM NaCl, 1% Triton X-100, and the
protein concentration of lysateswas analyzed using theBio-Rad
DC detection kit and bovine albumin standards. Cell lysates (50
g) were electrophoresed on 9% SDS-polyacrylamide gels,
transferred to polyvinylidene difluoride membrane, and
blocked with 3% bovine serum albumin in 50 mM Trizma (Tris
base) (pH 7.5), 300 mM NaCl, 0.2% Tween 20 (TBST). Mem-
branes were incubated for 1 h at room temperature with a
1:1000 dilution of FLAGM2monoclonal antibody in 3% bovine
serum albumin/TBST. Immunoreactive bands were visualized
with a peroxidase-conjugated anti-rabbit IgG (1:4000 in 3%
bovine serum albumin/TBST) and enhanced chemilumines-
cence. For immunoprecipitation analyses, cells were serum-
starved in the presence of the broad spectrum MMP inhibitor
GM6001 (Chemicon, Temecula, CA), switched to serum con-
taining medium for 3 h, collected with lysis buffer (above), and
subjected to immunoprecipitation using anti-MT1-MMP
(hinge antibody, 1:4000 dilution) and protein G beads. Immu-
noprecipitates were electrophoresed on 9%polyacrylamide gels
and subjected toWestern blotting using anti-MT1-MMP cata-
lytic domain (1:4000) or anti-phospho-TXR antibodies (1:1000)
followed by ECL detection, as described above. Alternatively,
cells were treatedwith the serine-threonine phosphatase inhib-
itor Calyculin A (20 nm, 10 min), collected as above, and sub-
jected to immunoprecipitation using anti-phospho-Thr anti-
body (2 g). Immunoprecipitates were then subjected to
Western blotting with anti-FLAGM2.
Biotin Surface Labeling—To label cell surface proteins, cells
were incubated with the non-cell-permeable biotin analogue
Sulfo-NHS-LCBiotin (1mg/ml) for 25min on ice, washed three
times in cold 100 mmol/liter glycine in phosphate-buffered
saline and once in cold phosphate-buffered saline, and lysed in
modified radioimmunoprecipitation assay buffer (50 mmol/li-
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ter Tris (pH 7.5), 150 mmol/liter NaCl, 1% Triton X-100, 5
mmol/liter EDTA). Equivalent amounts (50–70g) of lysate, as
determined by the Bio-Rad protein assay, were incubated with
25–30 l NeutrAvidin protein overnight at 4 °C with gentle
agitation. The NeutrAvidin biotin-labeled lysate complex was
then washed five times in modified radioimmunoprecipitation
assay lysis buffer, resuspended in modified radioimmunopre-
cipitation assay lysis buffer plus sample dilution buffer with
2-mercaptoethanol, and prepared for Western blot analysis.
Cellular Migration—To assess cell motility, migration
through transwell membranes coated with a thin layer of colla-
gen (100 g/ml, 37 °C, 1 h) on both the upper and lower sur-
faces was evaluated as described below for invasion using an
incubation time of 18 h. To conduct in vitro scratch wound
assays, cells were plated in 8-well plates, cultured to confluence,
and serum-starved overnight. Two scratch wounds were made
in each well using a micropipette tip. Two points were ran-
domly selected, marked for each scratch, and photographed
using a digital camera at 0, 24, and 48 h. Five relative measure-
ments were taken for each of the four points for each experi-
mental condition using the MetaMorph Imaging System (Uni-
versal Imaging Corp., Downington, PA). These resulting five
measurements for each point were averaged and then normal-
ized based on the initial measurement for that point at 0 h. The
four normalized valueswere then averaged for each experimen-
tal condition. The data include results from three separate
assays.
Tomeasure haptotacticmigration, a colloidal goldmigration
assay was utilized. The collagen-colloidal gold coating was pre-
pared as previously described (17, 18) withminormodification.
Briefly, glass coverslips (22 mm2) in a 6-well plate were coated
with rat tail type I collagen (BD Biosciences) at a concentration
of 5 g/cm2 by slowly evaporating 2 ml of a 12 g/ml collagen
solution in 0.02 N acetic acid at room temperature. The colloi-
dal gold particles were prepared as follows. Distilled water (11.3
ml) was combined with 6 ml of 36.5 mM Na2CO3 and 1.5 ml of
17.4 mM AuCl4H (Fisher). The solution was heated with a
burner just to boiling, and 1.8ml of 0.1% formaldehyde (diluted
from 36.5–38% formalin) was added. In order to prevent dena-
turation of collagen, the solution was then cooled to below
70 °C. The cooled solution was layered over collagen-coated
coverslips (2 ml each) and incubated at room temperature for
1 h to allow absorption of gold particles to the coated collagen.
The unabsorbed gold salts were carefully rinsed off with culture
medium, preventing drying of the coverslip. 1  103 cells were
plated onto the coated coverslip and allowed to migrate for
24–48 h. The coverslips were then rinsed carefully with cold
phosphate-buffered saline on ice and fix with 3.7% formalde-
hyde on ice for 10 min. The coverslips were briefly rinsed with
phosphate-buffered saline following distilled water and
mounted on slides with gelvatol. The images of phagokinetic
track were acquired by dark field with a Nikon D100 camera
mounted on a NikonMicrophot-FXAmicroscope. The images
were then analyzed by Adobe Photoshop CS.
Cellular Invasion—Type I collagen was dissolved in 0.5 M
acetic acid at a concentration of 2 mg/ml. For invasion experi-
ments, the collagen stockwas neutralizedwith 100mMNa2CO3
(pH9.6) to a final concentration of 0.4mg/ml. Transwell inserts
(0.8 m; BD Biosciences) were coated on the underside with
500 l of collagen diluted to a concentration of 100 g/ml at
37 °C for 1 h. Collagen gels were prepared in the inner well by
adding 50 l of collagen (20 g) at room temperature and
allowing gels to air-dry overnight. Collagen-coated inserts were
then washed with minimum essential medium three times to
remove salts and used immediately. Cells were trypsinized and
washed with serum-free medium, and 1  105 cells were added
to the inner invasion chamber in a volume of 200 l. The outer
wells contained 400l of culturemedium.Cellswere allowed to
invade for 24–48 h as indicated; non-invading cells were
removed from inner wells using a cotton swab, and invading
cells adherent to the bottom of the membrane were fixed and
stained using a Diff-Quick staining kit (DADE AG,Miami, FL).
Invading cells were enumerated by dividing membranes into
four quadrants and counting the number of cells in three dis-
tinct areas for each quadrant under a 10 objective using an
ocular micrometer. Assays were performed in triplicate.
For Matrigel invasion assays, the inner well of transwell
inserts (0.8 m; BD Biosciences) were coated with 100 l of
Matrigel Basement Membrane Matrix at a concentration of 1
mg/ml and allowed to permeabilize at room temperature for
1 h. Unpermeabilized liquid was removed, and filters were
washed with serum-free medium and allowed to air dry. Cells
were trypsinized and washed with serum-free medium, and
3.75  105 cells were added to the inner invasion chamber in a
volumeof 500l. The outerwell contained 750l of cell culture
medium. Cells were allowed to invade for 18 h, as indicated;
non-invading cells were removed from inner wells using a cot-
ton swab, and invading cells adherent to the bottom of mem-
brane were fixed and stained using the Diff-Quick staining kit
(DADEAG). Invading cells were enumerated by dividingmem-
branes into four quadrants and counting the number of cells in
three distinct areas for each quadrant under a 10 objective
using an ocular micrometer.
Three-dimensional Collagen Culture—Three-dimensional
cultures were prepared by diluting type I rat tail collagen (BD
Biosciences) with 10 minimum Eagle’s medium (Invitrogen)
to a final concentration of 1.5 mg/ml. Cells (5  104) were
added to the collagen mixture prior to solidification. In parallel
control experiments, theMMP inhibitor TIMP-2 was included
at a final concentration of 5 g/ml (19). Following growth for
5–8 days in three-dimensional collagen, gels were dissolved
using bacterial collagenase (2 mg/ml; Worthington), and cell
number was evaluated by hemocytometry, as described (19).
Experiments were repeated in triplicate. In control experi-
ments, solidified collagen gels were prepared as described
above, with 5  104 cells being added to the gel surface follow-
ing collagen solidification.
RESULTS
MT1-MMP Is Phosphorylated on Cytoplasmic Thr567—To
investigate the hypothesis that MT1-MMP undergoes phos-
phorylation at residue Thr567 (Fig. 1A), in vitro kinase assays
were conducted using a synthetic peptide containing theMT1-
MMP tail sequence as substrate and recombinant PKC. Tail
peptide was incubated in the presence or absence of purified
PKC, and reactions were initiated in the presence or absence of
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the PKC-activating cofactors diacylglycerol and phosphatidyl-
serine (16). PKC-stimulated phosphorylation of the MT1-
MMP tail peptide was readily noted on autoradiograms (Fig.
1B), whereas 32P incorporationwas not observed in the absence
of PKC and was greatly diminished in the absence of PKC acti-
vators diacylglycerol and phosphatidylserine. HistoneH1, a rec-
ognized substrate for PKC, was used in these experiments as a
positive control for 32P incorporation. To further investigate the
hypothesis thatMT1-MMPundergoesphosphorylationat residue
Thr567, MT1-MMP was immunoprecipitated from whole cell
lysates using an antibody recognizing the hinge domain of MT1-
MMP, electrophoresed, electroblotted, and probed using an anti-
body specific to the phosphorylated PKC recognition sequence,
phospho-TXR (Fig. 1A). As shown in Fig. 1C, the phosphothreo-
nine antibody recognized a 55-kDa species co-migrating with
active MT1-MMP. Taken together, these studies suggest that
MT1-MMPcan be phosphorylated at residueThr567 and that this
event can occur in a PKC-dependent manner.
Expression of MT1-MMP Thr567 Mutants in Human Breast
Carcinoma Cells—Based on the observation that MT1-MMP
can be phosphorylated at Thr567, studies were undertaken to
characterize the effect of this modification on cell behavior. To
date, studies investigating the functional role of the cytoplasmic
tail have primarily involved deletion of the entire domain. This
approach makes it difficult to determine whether the observed
effects are due to the absence of specific sequences in the cyto-
plasmic domain or whether functional phenotypes are a pleio-
tropic effect of truncation. In order to investigate the potential
functional consequence(s) of Thr567 modification, a more spe-
cific approach was developed. Using site directed mutagenesis,
Thr567 was mutated to glutamic acid (T567E) to mimic consti-
tutive phosphorylation or alanine
(T567A) to represent a phospho-de-
fective mutation. Wild type MT1-
MMP (MT in Fig. 2) and cells trans-
fectedwith vector alone (CAT) were
used as controls. Constructs were
transfected into MDA-MB231
breast carcinoma cells, and stable
clones were obtained byG418 selec-
tion, fluorescence-activated cell
sorting, and immunoblotting for
MT1-MMP expression. Analysis of
whole cell lysates from wild type,
T567A, and T567E demonstrated
equivalent MT1-MMP expression
(Fig. 2A). Direct activation of pro-
MMP-2 (progelatinase-A) is a clas-
sical function of MT1-MMP (3,
20–23). MMP-2 is responsible for
degrading type IV collagen, a major
component of the basement mem-
brane (3). Gelatin zymography was
used to determine the effect of
Thr567 mutation on the ability of
MT1-MMP to catalyze pro-MMP-2
activation. Relative to wild type
cells, no reproducible change in
pro-MMP-2 activation was demonstrated by T567A or T567E
mutant cell lines (Fig. 2B), indicating that Thr567mutation does
not alter the ability ofMT1-MMP to act as an upstream effector
of MMP-2 activity. Since previous studies indicate that the
cytoplasmic tail alters the surface presentation of active MT1-
MMP by regulating its internalization from the cell surface (5,
6), studies were conducted to determine whether alteration of
residue Thr567 modulates basal MT1-MMP surface presenta-
tion. Surface labeling (Fig. 2C) and fluorescence-activated cell
sorting analysis (Fig. 2D) indicate surface presentation of wild
type and mutant MT1-MMP, with the T567E mutant exhibit-
ing relatively lower surface expression comparedwithwild type
MT1-MMP. In control experiments, cells expressing wild type
MT1-MMP or the T567E and T567A mutants were immuno-
precipitated with a phospho-Thr antibody, followed by West-
ern blotting with FLAGM2 antibody to detect only exogenous
epitope-taggedMT1-MMP (Fig. 2, E and F). These data show a
significant decrease in detection of phospho-Thr-modified
MT1-MMP in cells expressing mutant proteins.
Thr567 Modification and Cell Migration—Acquisition of
MT1-MMP expression stimulates migration in a variety of cell
types and requires focalized degradation of ECM components. In
addition tomodifying the ECM,MT1-MMP promotes migration
through interactionwith andmodificationof various cell adhesion
molecules (24, 25). A variety of assays were used to determine
whether Thr567 mutation affects the ability ofMT1-MMP to pro-
mote cell migration. A Boyden chamber migration assay was first
used to investigate possible phenotypic differences. Relative to
vector controls, all MT1-MMP-expressing cells exhibited
enhanced migration (Fig. 3A). Further, the T567E mutant exhib-
ited a small but statistically significant increase in chemotactic
FIGURE 1. Analysis of MT1-MMP cytoplasmic tail residue Thr567. A, schematic of the MT1-MMP cytoplasmic
tail sequence showing the location of Thr567 within the PKC consensus recognition sequence TXR. B, in vitro
kinase assays were conducted using a synthetic peptide containing the MT1-MMP tail sequence as substrate
and recombinant PKC. Reactions were carried out in the presence or absence of purified PKC and were
initiated in the presence or absence of diacylglycerol (DAG) and phosphatidylserine (PS), as indicated. Polypep-
tides were resolved by electrophoresis and analyzed by autoradiography. C, MT1-MMP was immunoprecipi-
tated from whole cell lysates using an antibody recognizing the hinge domain of MT1-MMP. Following elec-
trophoresis and electroblotting, immunoprecipitate (IP) blots were probed with antibody directed against the
MT1-MMP catalytic domain (left) or anti-phospho-TXR (right).
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FIGURE 2. Analysis of MT1-MMP Thr567 mutants. A, expression of MT1-MMP constructs. MDA-MB-231 cells were transfected with FLAG epitope-tagged
constructs containing either wild type MT1-MMP (MT), empty vector (CAT), or mutations at cytoplasmic residue Thr567 that either mimic (TE) or prevent (TA)
phosphorylation. Cells were lysed, and lysates were subjected to Western blotting using anti-FLAG M2 antibodies as described under “Experimental Proce-
dures.” mwt, molecular weight standards in kDa. B, gelatin zymography was performed on serum-free conditioned medium from cells transfected with empty
vector (vec), wild type MT1-MMP (MT), or the T567A and T567E mutants (TA and TE, respectively). Controls included cells transfected with wild type MT1-MMP
cultured in the presence of the broad spectrum MMP inhibitor GM6001 (MT/GM). Arrows a– c, the migration positions of pro-MMP-2, intermediate MMP-2, and
active MMP-2, respectively. C, surface expression of MT1-MMP constructs. Stable cell lines were generated that display comparable levels of MT1-MMP
expression in whole cell lysates. To evaluate surface presentation, surface proteins were first biotinylated with a non-cell-permeable biotin analog and lysed,
and lysates were precipitated with NeutrAvidin to isolate surface-associated proteins, followed by analysis for MT1-MMP by Western blotting using anti-FLAG
M2, as described under “Experimental Procedures.” D, fluorescence-activated cell sorting analysis was conducted using monoclonal M2 FLAG antibody and
AlexaTM 488-conjugated anti-mouse IgG secondary antibody to quantify the amount of cell surface MT1-MMP as described under “Experimental Procedures.”
E, cells transfected with wild type or mutant MT1-MMP were treated with the serine-threonine phosphatase inhibitor Calyculin A (20 nm, 10 min), and lysates
were subjected to immunoprecipitation using anti-phospho-Thr antibody (2 g). Immunoprecipitates were then subjected to Western blotting with anti-FLAG
M2, as described under “Experimental Procedures.” The arrow denotes the migration position of MT1-MMP. *, nonspecific binding. F, densitometric quantita-
tion of triplicate repeat experiments as in E.
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migration relative to wild type MT1-MMP (p  0.003) (Fig. 3A).
Collagen-driven single cell motility was then analyzed by a colloi-
dal gold assay (17, 26), wherein glass coverslips were coated with
colloidal gold, overlaid with type I collagen, and seeded as single
cells at low density, followed by quantitation of the phagokinetic
tracks made by migrating cells. Although expression of MT1-
MMP increased cell migration relative to vector controls (vec), no
significant difference in motility was observed between wild type,
T567A, and T567E cells (Fig. 3B). Previous studies have shown
that the cytoplasmic tail is required to promote motility in colloi-
dal goldassays (6).Our findings indicate that although thisdomain
is required to promote motility in this particular assay, this func-
tion is not influenced by Thr567 status. Another important physi-
ological functionofMT1-MMPis its ability to stimulatemigration
during wound closure. Assays were conducted to investigate the
potential role ofThr567mutation in cellmigrationwithin this con-
text. As demonstrated in Fig. 3C, there was no significant differ-
ence in the rate of wound closure between wild type, T567A, and
T567Emutants.
Thr567 Modification Enhances Cell Invasion—MT1-MMP
enzymaticactivityduringcellular invasion iscritical toestablishing
the metastatic potential of a carcinoma (19). Degradation of key
matrix components is a prerequisite for invasion of many tissues
and allows cells to invade neighboring tissues unchecked. To
assess the potential effect of Thr567 mutation on invasion effi-
ciency, the ability of MT1-MMPmutants to penetrate type I col-
lagen gels was first assessed, since previous studies have demon-
strated MT1-MMP to be a potent interstitial collagenase (7, 19).
Relative to vector controls, allMT1-MMP-expressing cells exhib-
ited enhanced ability to invade type I collagen gels, with T567E
cells as the most invasive (Fig. 4A). Because the ability to traverse
FIGURE 4. Analysis of cell invasion. The effect of Thr567 mutation on cell
invasion was analyzed using Boyden chambers overlaid with gels composed
of type I collagen (A) or Matrigel (B), as described under “Experimental Proce-
dures.” Cells were serum-starved overnight prior to incubation in coated Boy-
den chambers for 18 h at 37 °C and enumeration of invading cells. Results are
the averages of three independent experiments and are shown as percent-
ages relative to vector controls (designated 100%).
FIGURE 3. Analysis of cell migration. A, the effect of Thr567 mutation on
chemotactic migration was assessed using a Boyden chamber migration
assay. The underside of the chamber was coated with type I collagen (10
g/ml). Cells were serum-starved overnight, incubated in Boyden chambers,
and allowed to migrate for 3.5 h at 37 °C prior to enumeration of migrating
cells. Results are the averages of three independent experiments and are
shown as percentages relative to vector controls (designated 100%). B, the
colloidal gold migration assay was used to evaluate collagen-driven single
cell motility. Cells were serum-starved and allowed to migrate for 12 h prior to
quantitation of phagokinetic tracks by computer-assisted image analysis.
Results are the averages of three independent experiments and are shown as
percentages relative to vector controls (designated 100%). C, the effect of
Thr567 mutation on experimental wound closure was assessed using a scratch
wound assay. Cells were plated to confluence and serum-starved overnight.
Scratches were mechanically introduced to the monolayer using a micropi-
pette tip. Cells were incubated at 37 °C for 18 h. Results are expressed as
relative wound closure compared with wound width at time 0.
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the basement membrane is often critical to metastasis, the ability
ofMT1-MMPmutants to invadeMatrigel, a basementmembrane
extract, was investigated. Aswith type I collagen, T567E exhibited
statistically significant increased invasion through aMatrigel bar-
rier (Fig. 4B). Collectively, the observed phenotypic differences
suggest that the phospho-mimetic modification at Thr567 may
elicit an increased invasive response.
Thr567 Modification Enhances Three-dimensional Growth—
Expression of MT1-MMP confers a distinct growth advantage
to tumor cells within a three-dimensional matrix both in vitro
and in vivo relative to control cells (2, 19). Although these stud-
ies highlight MT1-MMP-dependent type I collagenolysis as a
requirement for growth in this environment, the specific
domain(s) responsible for this effect were not reported. To
determine the potential role of cytoplasmic tailmodification on
MT1-MMP-mediated three-dimensional growth, cells were
seeded within three-dimensional type I collagen gels and cul-
tured for 8 days prior to dissolution of the gel and quantitation
of cell proliferation (19). Because TIMP-2 acts as an inhibitor of
MT1-MMP activity (19), control experiments were conducted
in the presence of TIMP-2. Because MDA-MB-231 cells have a
mesenchymal-like phenotype, they do not grow asmulticellular
aggregates. However, cells expressing wild type MT1-MMP
exhibit reproducibly enhanced proliferation within a three-di-
mensional matrix relative to
untransfected control cells (Fig.
5A), growing as loose, elongated
clusters. Furthermore, the T567E
mutant exhibits a more aggressive
proliferation within three-dimen-
sional collagen gels (Fig. 5,A and B).
The enhanced three-dimensional
growth is suppressed in control
matrices containing TIMP-2, con-
firming the requirement of MT1-
MMP enzymatic activity (Fig. 5C).
In additional control experiments,
analysis of cell growth atop planar
two-dimensional collagen surfaces
illustrates similar growth rates for
wild type and T567E and T567A
mutants (data not shown). These
data suggest that the phosphoryla-
tion state of cytoplasmic Thr567 (as
represented byT567E)may regulate
growth within a three-dimensional
environment and thereby confer a
distinct pathological advantage to
more invasive cells that have pene-
trated into the collagen-rich extra-
cellular microenvironment.
DISCUSSION
Studies involving the epidermal
growth factor receptor indicate that
the cytoplasmic domain contains a
PKC consensus sequence at Thr654
(28–30). Phosphorylation at this
site inhibits mitogenic signal transduction from epidermal
growth factor receptor (29) and prevents receptor internaliza-
tion by restricting the receptor to cell surface caveolae (31).
Similar studies show that additional membrane proteins,
including the human insulin receptor (32) and IL-2 receptor
(33, 34), have cytoplasmic domains that are substrates for PKC.
In a similar fashion, threonine phosphorylation could poten-
tially modulate MT1-MMP trafficking and cell function.
Although the enzymatic activity of MT1-MMP has a
major role in both physiological and pathological processes,
events regulating its activity are not yet fully understood. A
growing body of work demonstrates that acquisition of
MT1-MMP expression alone promotes a metastatic pheno-
type, resulting in enhanced cell migration (24, 34, 35), inva-
sion of the basement membrane (3, 36), and three-dimen-
sional growth (27). Increasing evidence suggests that the
cytoplasmic tail may function as a regulatory domain con-
trolling these processes. This region modulates endocytosis
of the enzyme, thereby regulating the level of active MT1-
MMP at the cell surface (5, 6). As a functional consequence,
tail-truncated mutants were found to be less efficient at cell
migration and invasion (6). More recent work indicates that
tyrosine phosphorylation at the cytoplasmic tail plays a func-
tional role in cell migration, since mutants that cannot
FIGURE 5. Analysis of growth in three-dimensional collagen gels. A, three-dimensional cultures were pre-
pared by diluting type I rat tail collagen with complete medium to a final concentration of 1.5 mg/ml. A, cells
(5  104) were seeded into the collagen mixture prior to solidification. Gels were allowed to incubate at 37 °C for 8
days and were photographed using phase-contrast microscopy. B, quantitation of proliferation within three-dimen-
sional collagen gels was performed by dissolution of the gels using bacterial collagenase, followed by hemocytom-
etry, as described under “Experimental Procedures” (19). C, in control experiments, the MMP inhibitor TIMP-2 was
also included at a final concentration of 5 g/ml (right), and the experiment was performed as in A.
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undergo phosphorylation at this residue are less efficient at
promoting cell migration in response to chemoattractants
(13). The mechanism(s) underlying the ability of the tail to
function in this capacity is unclear.
Results yielded in the present studies underscore a pivotal
role for the cytoplasmic tail in regulating MT1-MMP function.
Although regulatory factors that control this event are cur-
rently unknown, our findings support the occurrence of phos-
phorylation at Thr567 in theMT1-MMP cytoplasmic tail. Char-
acterization of Thr567 mutants that mimic constitutive
phosphorylation (T567E) demonstrate that this specific modi-
fication functions in the regulation of several cellular events
tied to MT1-MMP activity. In particular, the current data sug-
gest that, although the surface presentation is somewhat dimin-
ished, the T567E mutant displays enhanced collagenolytic
activity relative to wild type MT1-MMP. Although elucidation
of the precise mechanism for increased collagenolysis requires
further experimentation, it is possible that T567E mutation
(and, by extension, Thr567 phosphorylation) may enhance cat-
alytic efficiency of collagen cleavage through a conformational
alteration of the proteinase. Alternative mechanisms are also
feasible. For example, T567E mutation may result in altered
surface retention or retention in a specificmembranemicrodo-
main in which collagenolytic activity is more efficient. Other
MT1-MMP-trafficking mechanisms may also be affected by
cytoplasmic tail alteration.
The T567E mutant exhibits enhanced invasion through a
basementmembrane extract and type I collagen relative to con-
trol, wild type, and T567A cell lines. This phenotype is of path-
ological significance, because basement membrane penetra-
tion, followed by invasion of the underlying stroma, facilitates
metastasis and disease progression.
Interestingly, although there was no significant difference
between cell lines inwound closure or single cell randommotil-
ity, as detected bymigration on colloidal gold, the presence of a
phospho-mimetic at Thr567 does confer an advantage in che-
motactic migration. Successful motility in this assay requires
cytoskeletal polarization at the leading edge of the cell and
three-dimensional invasion through the filter in response to
chemical stimuli (collagen on the underside of the filter in this
example). In contrast, colloidal gold and wound closure assays
assess two-dimensional migration. In vivo, the physical local-
ization ofMT1-MMP is critical during cell migration and inva-
sion through the surroundingmatrix. Although themechanism
underlying the superior function of T567E in chemotactic
migration and ECM invasion is unclear, it is possible that phos-
phorylation at this residue may alter the ability of MT1-MMP
to localize at the invading front of the cell. This may occur
through a direct mechanism or by indirectly interfering with
the ability of MT1-MMP to spatially interact with other cell
molecules that function in lamellipodia formation.
The cell adhesionmoleculeCD44plays a direct role in direct-
ingMT1-MMP localization to lamellipodia (37). During motil-
ity, CD44 localizes to the leading edge of the cell by binding the
cytoskeletal component F actin with its cytoplasmic domain
(38). CD44 binds the hemopexin domain of MT1-MMP
through its stem, indirectly linking MT1-MMP to the cell
cytoskeleton. Disruption of this association inhibits the inter-
action between the two molecules and diminishes the ability of
MT1-MMP to localize to lamellipodia (37). Although improp-
erly localizedMT1-MMP retains the ability to activateMMP-2,
it is unable to promote matrix turnover or cell invasion (39).
The implication of this is that regulated localization at inv-
adapodia is tightly linked toMT1-MMP function. It is plausible
that Thr567 phosphorylation may alter the ability of the protein
to spatially interact with the invasion machinery during
cytoskeletal reorganization of the leading edge. Alternately, the
phenotypic differences demonstrated by T567E and T567A
mutants may be due to changes in MT1-MMP trafficking and
membrane microdomain localization, similar to data showing
that PKC-induced phosphorylation of epidermal growth factor
receptor Thr654 modulates mitogenic signaling by regulating
both internalization and localization to caveolae (29, 31). A cor-
responding alteration in trafficking and cellular locale would
influence activities that require proper localization of MT1-
MMP, including migration, invasion, and protein interactions.
Perhaps themost interesting phenotypic finding is the ability
of the T567E phospho-mimetic mutation to enhance three-
dimensional growth within a collagen matrix. Cancer progres-
sion is characterized by increased growth atop the basement
membrane, followed by invasion and proliferation within the
three-dimensional environment of the stromal matrix (27, 40,
41). Composed largely of type I collagen or fibrin (40, 41), inva-
sive carcinomasmust demonstrate a distinct growth advantage
within the constrained environment provided by the stroma. It
has been established that MT1-MMP expression is required for
three-dimensional growth (27), and we have previously demon-
strated that collagen invasion by MDA-MB-231 cells is an MT1-
MMP-dependent process (42). Although these studies identify
MT1-MMP-dependent type I collagenolysis as a requirement
for this observed growth advantage, the specific domain(s)
responsible for this action have yet to be delineated. Although
T567E cells demonstrate enhanced proliferation in these
assays, analysis of cell growth atop collagen surfaces illustrates
similar growth rates for wild type, T567E, and T567Amutants.
These data suggest that the phosphorylation state at cytoplas-
mic tail residue Thr567 may function as a molecular switch to
either enhance or inhibit growth within a matrix. Lack of a phe-
notypic difference between mutants atop collagen surfaces sug-
gests that the advantage afforded by thismodification is specific to
more invasive cells that are functioning within a three-dimen-
sional environment, similar to that encountered in the stroma.
In addition to modulating internalization (5, 6), the results
presented herein indicate that the cytoplasmic tailmay regulate
several aspects of MT1-MMP enzymatic function through
phosphorylation of the unique Thr567 residue. These findings
suggest that strategies to block Thr567 phosphorylation may
subdue cellular characteristics associated with more aggressive
tumors, including enhanced invasion of and proliferation
within dense collagen gels, and may represent an alternative
strategy to peptide hydroxamate-based MMP inhibitors.
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